Maureen Shanahan

Mo Shanahan has a diverse and extensive work experience in the medical and pharmaceutical field. Maureen "Mo" is currently the Director of Medical Science Liaisons at Fractyl Health, a position they have held since April 2022. Prior to this, they worked as an Associate Director of Medical Science Liaisons at Fractyl Health from September 2020 to April 2022.

Before joining Fractyl Health, Mo held various roles at BD, a medical technology company, from December 2012 to September 2020. Maureen "Mo" served as a Senior Medical Science Liaison, specializing in diabetes.

From May 2010 to December 2012, Mo worked as an Associate Director of Cardiometabolic Medical Science Liaison at Boehringer Ingelheim Pharmaceuticals, a leading pharmaceutical company.

Maureen "Mo" also worked as a Metabolic Medical Science Liaison at Novo Nordisk A/S from 2009 to 2010.

Prior to their roles in the pharmaceutical industry, Mo worked as a Clinical Pharmacist in the ICU at the Veterans Health Administration from 2008 to 2009.

Between 2006 and 2007, they served as a Medical Science Liaison at Medikinetics/iDOC/Metamorphosis.

Mo's earlier experiences include serving as a Metabolic Senior Medical Science Liaison at Amylin Pharmaceuticals from 2001 to 2005 and as a Metabolic Clinical Liaison at Roche Pharmaceuticals from 1997 to 2001.

Maureen "Mo" started their career as the Director of Pharmacy at Gifford Medical Center from February 1992 to May 1997.

Mo's first role in the field was as a Clinical Pharmacy Coordinator at the Veterans Administration Hosp from 1987 to 1992.

Maureen "Mo" Shanahan, MSHA, RPh earned a Bachelor of Science (BS) degree in Pharmacy from the University of North Carolina at Chapel Hill, where they studied from 1975 to 1980. Later, they pursued a Master of Science in Healthcare Administration (MSHA) from the University of Colorado Denver, completing their studies from 1996 to 1998.